胺碘酮在心律失常治疗中的应用研究  

Clinical Study on Amiodarone in Treatment of Arrhythmia

作　　者：唐博弢[1] 

机构地区：[1]黑龙江省森工总医院心内二科,黑龙江哈尔滨150040

出　　处：《中国卫生标准管理》2016年第10期82-83,共2页China Health Standard Management

摘　　要：目的对胺碘酮在心律失常治疗中的临床应用效果进行分析研究。方法选取于2014年4月~2015年12月我院收治的心律失常患者113例,并随机分为对照组（54例）和实验组（59例）,对分别应用普鲁帕酮和胺碘酮治疗的临床疗效进行对照研究。结果实验组患者的显效率、治疗总有效率均高于对照组（66.10%、91.53%vs.40.74%、72.22%）,不良反应发生率低于对照组（6.78%vs.29.63%）,组间差异有统计学意义（P〈0.05）。结论胺碘酮在心律失常治疗中的临床应用效果十分理想。Objective Clinical amiodarone effect in treatment of patients with arrhythmia is to be studied. Methods Chose 113 patients with arrhythmia who were treated in hospital from April 2014 to December 2015 and separate them into control group（54 patients）and study group（59 patients）at random,and then observed and compared propafenone treatment effect to amiodarone effect between two groups. Results Patients＇ explicit efficacy and treatment efficiency in study group were much higher than those in control group（66.10%、91.53% vs. 40.74%、72.22%）. Besides,side-effect incidence in study group was much lower than that in control group（6.78% vs. 29.63%）,there was a differential between two groups and such a differential had statistic value（P〈0.05）. Conclusion Amiodarone is quite effective in treatment of patients with arrhythmia.

关 键 词：胺碘酮 心律失常 

分 类 号：R972[医药卫生—药品]